Pro DEX price to free cash flow PDEX
Market value divided by free cash flow over the last twelve months, since 2015.
- Today, Nov 2, 2026
- 17.3×
- 10-year median
- 21.5×
- Against its 10-year history
- 34th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 7.8× to 63.2×
- Peer median
- 12.0×
Pro DEX's price to free cash flow is 17.3× as of Nov 2, 2026.
That is below its ten-year median of 21.5×, lower than on 66% of days in the last ten years.
Over that time it ranged from 7.8× in Feb 2018 to 63.2× in Dec 2020.
The median for 10 medical instruments and supplies stocks of a similar size is 12.0×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 17.3× | 17.3× | 34.8× |
| 2025 | n/m a value too high to mean anything | ||
| 2024 | n/m a value too high to mean anything | ||
| 2023 | 14.2× | 14.1× | 14.2× |
| 2022 | n/m a value too high to mean anything | ||
| 2021 | 37.6× | 30.1× | 48.0× |
| 2020 | 45.9× | 16.9× | 63.2× |
| 2019 | 25.2× | 13.7× | 44.0× |
| 2018 | 36.6× | 7.8× | 43.1× |
| 2017 | 8.3× | 8.1× | 23.1× |
| 2016 | n/m a value too high to mean anything | ||
| 2015 | 25.3× | 24.8× | 29.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Pro DEX's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| PDEXPro DEX | 17.3× |
| UTMDUtah Medical Products | 19.6× |
| INFUInfuSystem | 12.0× |
| EMBCEmbecta | 2.1× |
| KEQUKewaunee Scientific | 8.9× |
| TCMDTactile Systems Technology | 19.3× |
| APTAlpha Pro Tech | 9.6× |
| MOVMovado | 10.0× |
| NEPHNephros | n/m |
| IRMDIradimed | 38.9× |
| IARTIntegra Lifesciences | 12.3× |
| Peer median | 12.0× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Pro DEX
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.